Scientists test Custom-Made vaccine to fight deadly brain cancer
NCT ID NCT07422896
Summary
This is a first-in-human safety study testing a personalized vaccine called Bvax for people newly diagnosed with glioblastoma, a fast-growing brain cancer. The vaccine is made from the patient's own blood cells and tumor tissue and is given alongside standard chemotherapy and radiation. The main goal is to see if this combined approach is safe and feasible, while also checking for early signs that it might help control the cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Northwestern University
Chicago, Illinois, 60611, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.